226 related articles for article (PubMed ID: 22210625)
1. Impaired neural development in a zebrafish model for Lowe syndrome.
Ramirez IB; Pietka G; Jones DR; Divecha N; Alia A; Baraban SC; Hurlstone AF; Lowe M
Hum Mol Genet; 2012 Apr; 21(8):1744-59. PubMed ID: 22210625
[TBL] [Abstract][Full Text] [Related]
2. The Lowe syndrome protein OCRL1 is required for endocytosis in the zebrafish pronephric tubule.
Oltrabella F; Pietka G; Ramirez IB; Mironov A; Starborg T; Drummond IA; Hinchliffe KA; Lowe M
PLoS Genet; 2015 Apr; 11(4):e1005058. PubMed ID: 25838181
[TBL] [Abstract][Full Text] [Related]
3. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.
Choudhury R; Diao A; Zhang F; Eisenberg E; Saint-Pol A; Williams C; Konstantakopoulos A; Lucocq J; Johannes L; Rabouille C; Greene LE; Lowe M
Mol Biol Cell; 2005 Aug; 16(8):3467-79. PubMed ID: 15917292
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the Lowe syndrome protein OCRL1.
Lowe M
Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
[TBL] [Abstract][Full Text] [Related]
5. The Lowe syndrome protein OCRL1 is involved in primary cilia assembly.
Coon BG; Hernandez V; Madhivanan K; Mukherjee D; Hanna CB; Barinaga-Rementeria Ramirez I; Lowe M; Beales PL; Aguilar RC
Hum Mol Genet; 2012 Apr; 21(8):1835-47. PubMed ID: 22228094
[TBL] [Abstract][Full Text] [Related]
6. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P
Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W
J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724
[TBL] [Abstract][Full Text] [Related]
7. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
[TBL] [Abstract][Full Text] [Related]
8. The cellular and physiological functions of the Lowe syndrome protein OCRL1.
Mehta ZB; Pietka G; Lowe M
Traffic; 2014 May; 15(5):471-87. PubMed ID: 24499450
[TBL] [Abstract][Full Text] [Related]
9. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
[TBL] [Abstract][Full Text] [Related]
10. Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase.
Coon BG; Mukherjee D; Hanna CB; Riese DJ; Lowe M; Aguilar RC
Hum Mol Genet; 2009 Dec; 18(23):4478-91. PubMed ID: 19700499
[TBL] [Abstract][Full Text] [Related]
11. OCRL1 modulates cilia length in renal epithelial cells.
Rbaibi Y; Cui S; Mo D; Carattino M; Rohatgi R; Satlin LM; Szalinski CM; Swanhart LM; Fölsch H; Hukriede NA; Weisz OA
Traffic; 2012 Sep; 13(9):1295-305. PubMed ID: 22680056
[TBL] [Abstract][Full Text] [Related]
12. Role of Ocrl1 in primary cilia assembly.
Madhivanan K; Ramadesikan S; Aguilar RC
Int Rev Cell Mol Biol; 2015; 317():331-47. PubMed ID: 26008789
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndrome.
Hagemann N; Hou X; Goody RS; Itzen A; Erdmann KS
Small GTPases; 2012; 3(2):107-10. PubMed ID: 22790198
[TBL] [Abstract][Full Text] [Related]
14. Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases.
Hyvola N; Diao A; McKenzie E; Skippen A; Cockcroft S; Lowe M
EMBO J; 2006 Aug; 25(16):3750-61. PubMed ID: 16902405
[TBL] [Abstract][Full Text] [Related]
15. PTEN reduces endosomal PtdIns(4,5)P
Mondin VE; Ben El Kadhi K; Cauvin C; Jackson-Crawford A; Bélanger E; Decelle B; Salomon R; Lowe M; Echard A; Carréno S
J Cell Biol; 2019 Jul; 218(7):2198-2214. PubMed ID: 31118240
[TBL] [Abstract][Full Text] [Related]
16. Lowe syndrome protein Ocrl1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology.
Faucherre A; Desbois P; Nagano F; Satre V; Lunardi J; Gacon G; Dorseuil O
Hum Mol Genet; 2005 Jun; 14(11):1441-8. PubMed ID: 15829501
[TBL] [Abstract][Full Text] [Related]
17. A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.
Hou X; Hagemann N; Schoebel S; Blankenfeldt W; Goody RS; Erdmann KS; Itzen A
EMBO J; 2011 Apr; 30(8):1659-70. PubMed ID: 21378754
[TBL] [Abstract][Full Text] [Related]
18. The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function.
Lichter-Konecki U; Farber LW; Cronin JS; Suchy SF; Nussbaum RL
Mol Genet Metab; 2006; 89(1-2):121-8. PubMed ID: 16777452
[TBL] [Abstract][Full Text] [Related]
19. Differential clathrin binding and subcellular localization of OCRL1 splice isoforms.
Choudhury R; Noakes CJ; McKenzie E; Kox C; Lowe M
J Biol Chem; 2009 Apr; 284(15):9965-73. PubMed ID: 19211563
[TBL] [Abstract][Full Text] [Related]
20. OCRL1 engages with the F-BAR protein pacsin 2 to promote biogenesis of membrane-trafficking intermediates.
Billcliff PG; Noakes CJ; Mehta ZB; Yan G; Mak L; Woscholski R; Lowe M
Mol Biol Cell; 2016 Jan; 27(1):90-107. PubMed ID: 26510499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
